Dynasil’s RMD Subsidiary Awarded $3.45 Million in Technology Development Grants by U.S. Department of Energy

  Dynasil’s RMD Subsidiary Awarded $3.45 Million in Technology Development
  Grants by U.S. Department of Energy

Business Wire

WATERTOWN, Mass. -- October 02, 2012

Dynasil Corporation of America (NASDAQ: DYSL) today announced that its
contract research subsidiary, RMD Inc., has received grants totaling $3.45
million under the U.S. Department of Energy’s Small Business Innovation
Research (SBIR) and Small Business Technology Transfer (STTR) Programs.

“RMD continues to be recognized as providing world class research in the areas
of scintillation, sensing and nondestructive testing technologies,” said Peter
Sulick, Dynasil’s Chairman of the Board, Interim Chief Executive Officer and
President. “These awards underscore RMD’s pivotal role in applying material
science and non destructive technologies to new detection and analysis methods
for the government’s most critical security, industrial, energy and medical
objectives.”

Three Phase II Grants

SBIR/STTR Phase II DOE programs represent funding for the principal R&D
effort, with awards up to $1 million over two years. RMD received three Phase
II grants of $1 million each for the following:

  *Eddy Current Technology –Further development of the Company’s magnetic
    solid-state sensor arrays for through-wall inspection of nuclear power
    plant components.
  *High-Resolution Scintillators – Continued engineering of high-resolution
    scintillators to enhance current state-of-the-art X-ray detection
    technology for applications such as synchrotron studies, homeland security
    as well as medical research for drug development.
  *High-Resolution Sensors –Development of the new scintillator materials for
    advanced analysis of electromagnetic radiation, which is used in areas
    such as scanning equipment at ports, airports and border crossings and
    medical imaging.

“From the development of imaging devices designed to 'see' through the walls
of nuclear power plant components to neutron detectors that can recognize the
chemical signature of a dirty bomb, the Phase II research projects we are
embarking on through these SBIR/STTR Programs embody some of the world’s most
pressing security needs,” said Kanai Shah, Ph.D. President of Dynasil’s RMD
subsidiary. “Dynasil is proud to partner with the Department of Energy on
these initiatives.”

Three Phase I Grants

In addition to the Phase II grants, RMD was awarded three Phase I grants of
$150,000 each. SBIR/STTR Phase I DOE programs explore the feasibility of
innovative concepts, with awards up to $150,000 over nine months.

“Each of these Phase I grants capitalizes on our technical and scientific
expertise in the development of scintillation materials and solid state
sensors for nuclear detection,” Kanai Shah said. “Our work has significant
application in the prevention of terrorist attacks and the non-proliferation
of nuclear materials, as well as in commercial endeavors such as energy
exploration, nuclear power plant safety, medical imaging, basic science
studies and non-destructive testing."

About Dynasil

Dynasil Corporation of America (NASDAQ: DYSL) develops and manufactures
detection and analysis technology, precision instruments and optical
components for the homeland security, medical and industrial markets.
Combining world-class technology with expertise in research and materials
science, Dynasil is commercializing products including dual-mode radiation
detection solutions for Homeland Security and commercial applications, probes
for medical imaging and sensors for non-destructive testing. Dynasil has an
impressive and growing portfolio of issued and pending U.S. patents. The
Company is based in Watertown, Massachusetts, with additional operations in
Mass., Minn., NY, NJ and the United Kingdom. More information about the
Company is available at www.dynasil.com.

Forward-looking Statements

This news release may contain forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These forward-looking
statements regarding future events and our future results are based on current
expectations, estimates, forecasts, and projections and the beliefs and
assumptions of our management. These forward-looking statements may be
identified by the use of words such as “may,” “could,” “expect,” “estimate,”
“anticipate,” “continue” or similar terms, though not all forward-looking
statements contain such words. The actual results of the future events
described in such forward-looking statements could differ materially from
those stated in such forward-looking statements due to a number of important
factors. These factors that could cause actual results to differ from those
anticipated or predicted include, without limitation, our ability to develop
and commercialize our products, including our dual mode detectors and the
development of new technologies including at Dynasil Biomedical, the size and
growth of the potential markets for our products and our ability to serve
those markets, the rate and degree of market acceptance of any of our
products, general economic conditions, costs and availability of raw materials
and management information systems, our ability to obtain and maintain
intellectual property protection for our products, competition, the loss of
key management personnel, litigation, the effect of governmental regulatory
developments, the availability of financing sources, our ability to identify
and execute on acquisition opportunities and integrate such acquisitions into
our business, and seasonality, as well as the uncertainties set forth in the
Company’s Annual Report on Form 10-K and from time to time in the Company's
other filings with the Securities and Exchange Commission. The Company
disclaims any intention or obligation to update any forward-looking
statements, whether as a result of new information, future events or
otherwise.

Contact:

Dynasil Corporation of America
Patty Kehe, 617-668-6855
pkehe@dynasil.com
or
Sharon Merrill
David Calusdian, 617-542-5300
Executive Vice President and Partner
DYSL@InvestorRelations.com
 
Press spacebar to pause and continue. Press esc to stop.